课题基金 / 基金详情

A novel mechanism of translational regulation in bacteria: de-repression of non-canonical start codons in response to oxidative stress

A novel mechanism of translational regulation in bacteria: de-repression of non-canonical start codons in response to oxidative stress
细菌翻译调控的新机制:响应氧化应激而解除非规范起始密码子的抑制
批准号:
BB/L019825/1
负责人:
Mark Buttner
金额:
$59.94万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --

项目摘要

项目成果

Mark Buttner的其他基金

相似基金

相关文献

中文摘要
翻译
被称为链霉菌的无害土壤细菌对人类福利至关重要,因为它们是医生用于治疗传染病的绝大多数抗生素的来源,也为我们提供了许多其他药物,例如用于治疗癌症和帮助器官移植患者。我们已经确定了一种主调节因子(称为“转录因子”),它可以切换这些有用细菌的遗传机制,使它们能够在称为活性氧的有毒分子(一种称为“氧化应激”的条件)存在下生存。这项工作的目的是找出这个主调节器的活性是如何在分子水平上控制的。我们还知道,同样的主调节器控制着病原体结核分枝杆菌和白喉棒状杆菌对氧化应激的抵抗力,这两种细菌分别导致致命的结核病和白喉。这一点很重要,因为白色血细胞摄取致病菌,并将它们暴露于活性氧物质中以杀死它们,因此致病菌如M.结核和C.白喉抵抗这种氧化杀伤对人类健康潜在地重要。
英文摘要
The harmless soil bacteria called streptomycetes are vital to human welfare because they are the source of the vast majority of antibiotics used by doctors to cure infectious diseases, as well as providing us with numerous other medicines used, for example, to treat cancer, and to help organ transplant patients. We have identified a master regulator (called a 'transcription factor') that switches the genetic machinery of these useful bacteria to allow them to survive in the presence of toxic molecules called Reactive Oxygen Species (a condition called "oxidative stress"). The aim of this work is to find out exactly how the activity of this master regulator is controlled at the molecular level. We also know that this same master regulator controls resistance to oxidative stress in the pathogens Mycobacterium tuberculosis and Corynebacterium diphtheriae, the bacteria that cause the fatal diseases tuberculosis and diphtheria, respectively. This is important because white blood cells ingest pathogenic bacteria and expose them to Reactive Oxygen Species in order to kill them, and so the mechanisms by which disease-causing bacteria like M. tuberculosis and C. diphtheriae resist this oxidative killing are potentially important to human health.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1128/mbio.00815-17
发表时间: 2017-06-13
期刊: mBio
影响因子: 6.4
作者: [Feeney MA, Chandra G, Findlay KC, Paget MSB, Buttner MJ]
通讯作者: Buttner MJ
DOI: 10.1073/pnas.1704612114
发表时间: 2017-07-25
期刊: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子: 11.1
作者: [Schlimpert, Susan, Wasserstrom, Sebastian, Buttner, Mark J.]
通讯作者: Buttner, Mark J.
DOI: 10.1128/mbio.00523-16
发表时间: 2016-04-19
期刊: mBio
影响因子: 6.4
作者: [Bush MJ, Chandra G, Bibb MJ, Findlay KC, Buttner MJ]
通讯作者: Buttner MJ
DOI: 10.3791/53863
发表时间: 2016-02-28
期刊: Journal of visualized experiments : JoVE
影响因子: --
作者: [Schlimpert S, Flärdh K, Buttner J]
通讯作者: Buttner J
The role of the dynamin membrane-remodelling proteins in developmentally controlled cell division in Streptomyces
  • 批准号:
    BB/P001041/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $60.39万
  • 财政年份:
    2017
  • 负责人:
    Mark Buttner
  • 依托单位:
ERASynBio2: An orthogonal, organism-independent expression platform based on extracytoplasmic function (ECF) sigma factors
  • 批准号:
    BB/N006852/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $51.81万
  • 财政年份:
    2015
  • 负责人:
    Mark Buttner
  • 依托单位:
Molecular mechanism of environmental stress sensing by bacterial Zinc-containing Anti-Sigma factors
  • 批准号:
    BB/I00873X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $57.84万
  • 财政年份:
    2011
  • 负责人:
    Mark Buttner
  • 依托单位:
Integration and coordination within complex antibiotic biosynthetic pathways
  • 批准号:
    BB/I002197/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $58.94万
  • 财政年份:
    2011
  • 负责人:
    Mark Buttner
  • 依托单位:
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
  • 批准号:
    82371332
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    胡琴
  • 依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
  • 批准号:
    82371103
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    阮静
  • 依托单位: